Showing 1 - 3 results of 3 for search 'Jose Manuel Carrascosa', query time: 0.01s Refine Results
  1. 1
    Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

    Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis by Tiago Torres, Anne Sohrt Petersen, Ulla Ivens, Albert Bosch Vilaro, John Stinson, José Manuel Carrascosa

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study

    An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study by Carlos Marras, María Labarga, Daniel Ginard, Jose Manuel Carrascosa, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Fernando de Mora, Tamara Robles, Elisa Romero, Rafael Martínez

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment

    Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment by Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, Jose-Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline Pierce, Helena Agell, Sonja Ständer

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: